Kun‐Lung Chuang

521 total citations
13 papers, 429 citations indexed

About

Kun‐Lung Chuang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kun‐Lung Chuang has authored 13 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Kun‐Lung Chuang's work include Bladder and Urothelial Cancer Treatments (6 papers), Urinary and Genital Oncology Studies (4 papers) and Prostate Cancer Treatment and Research (3 papers). Kun‐Lung Chuang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Urinary and Genital Oncology Studies (4 papers) and Prostate Cancer Treatment and Research (3 papers). Kun‐Lung Chuang collaborates with scholars based in Taiwan, United States and Japan. Kun‐Lung Chuang's co-authors include Cheng‐Keng Chuang, See‐Tong Pang, Heng‐Chang Chuang, Ying‐Hsu Chang, Shuyuan Yeh, Hung‐Wei Yang, Mu‐Yi Hua, Rung‐Ywan Tsai, W.J. Chen and Shinichi Yamashita and has published in prestigious journals such as Biomaterials, The Journal of Urology and Carcinogenesis.

In The Last Decade

Kun‐Lung Chuang

13 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun‐Lung Chuang Taiwan 8 156 148 127 101 71 13 429
Zuquan Xiong China 12 81 0.5× 135 0.9× 113 0.9× 99 1.0× 43 0.6× 26 470
Xiao Gu China 13 217 1.4× 206 1.4× 60 0.5× 74 0.7× 77 1.1× 27 597
Naoki Makita Japan 11 85 0.5× 212 1.4× 137 1.1× 81 0.8× 39 0.5× 39 501
Marco Soster Italy 11 81 0.5× 201 1.4× 121 1.0× 195 1.9× 35 0.5× 15 597
Wen Song China 11 96 0.6× 226 1.5× 88 0.7× 108 1.1× 35 0.5× 34 500
Youqiang Fang China 11 114 0.7× 200 1.4× 80 0.6× 94 0.9× 46 0.6× 32 467
Tanner K. Hill United States 10 83 0.5× 146 1.0× 186 1.5× 261 2.6× 47 0.7× 11 516
Jonathan S. Rink United States 13 70 0.4× 249 1.7× 181 1.4× 157 1.6× 111 1.6× 29 617
Shiqiang Zhang China 13 71 0.5× 128 0.9× 89 0.7× 112 1.1× 52 0.7× 30 404
Chengming Zhou China 12 62 0.4× 183 1.2× 198 1.6× 120 1.2× 39 0.5× 21 501

Countries citing papers authored by Kun‐Lung Chuang

Since Specialization
Citations

This map shows the geographic impact of Kun‐Lung Chuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun‐Lung Chuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun‐Lung Chuang more than expected).

Fields of papers citing papers by Kun‐Lung Chuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun‐Lung Chuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun‐Lung Chuang. The network helps show where Kun‐Lung Chuang may publish in the future.

Co-authorship network of co-authors of Kun‐Lung Chuang

This figure shows the co-authorship network connecting the top 25 collaborators of Kun‐Lung Chuang. A scholar is included among the top collaborators of Kun‐Lung Chuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun‐Lung Chuang. Kun‐Lung Chuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hsu, Iawen, et al.. (2013). Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development. Carcinogenesis. 35(3). 651–661. 66 indexed citations
2.
Yamashita, Shinichi, Kuo-Pao Lai, Kun‐Lung Chuang, et al.. (2012). ASC-J9 Suppresses Castration-Resistant Prostate Cancer Growth through Degradation of Full-length and Splice Variant Androgen Receptors. Neoplasia. 14(1). 74–IN12. 120 indexed citations
3.
Yamashita, Shinichi, Kuo‐Pao Lai, Kun‐Lung Chuang, et al.. (2012). 960 ASC-J9® SUPPRESSES CASTRATION-RESISTANT PROSTATE CANCER GROWTH VIA DEGRADATION OF FULL-LENGTH AND SPLICE VARIANT ANDROGEN RECEPTORS. The Journal of Urology. 187(4S). 3 indexed citations
4.
Hua, Mu‐Yi, Hung‐Wei Yang, Hao-Li Liu, et al.. (2011). Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy. Biomaterials. 32(34). 8999–9010. 73 indexed citations
5.
Chang, Ying‐Hsu, Cheng‐Keng Chuang, See‐Tong Pang, et al.. (2011). Prognostic value of TNM stage and tumor necrosis for renal cell carcinoma. The Kaohsiung Journal of Medical Sciences. 27(2). 59–63. 11 indexed citations
6.
Chuang, Kun‐Lung, Shuen‐Kuei Liao, See‐Tong Pang, et al.. (2010). Mixed germ cell tumor metastatic to the skin: Case report and literature review. World Journal of Surgical Oncology. 8(1). 21–21. 9 indexed citations
7.
Pang, See‐Tong, et al.. (2010). Age-related reference levels of serum prostate-specific antigen among Taiwanese men without clinical evidence of prostate cancer.. PubMed. 33(2). 182–7. 16 indexed citations
8.
Hua, Mu‐Yi, Hung‐Wei Yang, Cheng‐Keng Chuang, et al.. (2010). Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer. Biomaterials. 31(28). 7355–7363. 100 indexed citations
9.
Chuang, Cheng‐Keng, et al.. (2010). Epstein-Barr virus-infected cell line TCC36B derived from B lymphocytes infiltrating renal pelvis urothelial carcinoma.. PubMed. 30(9). 3473–8. 2 indexed citations
10.
Chuang, Kun‐Lung, See‐Tong Pang, Shuen‐Kuei Liao, et al.. (2010). Epstein–Barr virus DNA load in tumour tissues correlates with poor differentiation status in non‐muscle invasive urothelial carcinomas. British Journal of Urology. 107(1). 150–154. 6 indexed citations
11.
Chuang, Kun‐Lung, Kwai‐Fong Ng, Chun‐Te Wu, et al.. (2009). Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients. British Journal of Urology. 105(10). 1413–1416. 6 indexed citations
12.
Chang, Chien‐Chung, Kun‐Lung Chuang, Cheng‐Keng Chuang, et al.. (2008). Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding β2-microglobulin genes. Cancer Immunology Immunotherapy. 58(3). 395–408. 11 indexed citations
13.
Lee, Ching-Yi, et al.. (2006). Bladder leiomyoma with right hydronephrosis. International Urogynecology Journal. 18(2). 215–217. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zuquan Xiong Breakdown of academic impact, for papers by Xiao Gu Breakdown of academic impact, for papers by Naoki Makita Breakdown of academic impact, for papers by Marco Soster Breakdown of academic impact, for papers by Wen Song Breakdown of academic impact, for papers by Youqiang Fang Breakdown of academic impact, for papers by Tanner K. Hill Breakdown of academic impact, for papers by Jonathan S. Rink Breakdown of academic impact, for papers by Shiqiang Zhang Breakdown of academic impact, for papers by Chengming Zhou
Rankless by CCL
2026